Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study

AIM: We aimed to compare neuropeptide levels between patients with major psychiatric disorders and healthy controls and examine their association with symptoms and cognitive function. METHODS: The participants were 149 patients with schizophrenia, 115 patients with bipolar disorder (BD), 186 unremit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidese, Shinsuke, Yoshida, Fuyuko, Ishida, Ikki, Matsuo, Junko, Hattori, Kotaro, Kunugi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009433/
https://www.ncbi.nlm.nih.gov/pubmed/36414415
http://dx.doi.org/10.1002/npr2.12304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009433/
https://www.ncbi.nlm.nih.gov/pubmed/36414415
http://dx.doi.org/10.1002/npr2.12304

Ejemplares similares